Assessment of Optic Nerve Changes in Patients Receiving Anti-Tuberculosis Drugs at Different Time Interval


  • Shakila Abbas
  • Sonia Abdul Sammad
  • Mariyam Akhtar
  • Syeda Tasneem Zahra
  • Syeda Najam Gulzar
  • Ayesha Kiran



Ethambutol, Isoniazid, Optic Neuropathy, Optic Nerve, Tuberculosis


Objectives: To assess optic nerve changes in patients receiving anti-tuberculosis drugs and to assess optic nerve changes
at different time interval of therapy.
Study design and settings: Descriptive cross-sectional study was conducted from August 2021 to November 2021 in
Madinah Teaching Hospital, Faisalabad.
Methodology: 200 eyes of 100 patients receiving anti-tuberculosis therapy since 2-month, 4-month, 6 month and 8 months
were taken. Patients had not any systemic disease other than Tuberculosis. Indirect Ophthalmoscopy was performed to
assess changes in fundus and optic nerve head. Optical Coherence Tomography was performed for assessment of retinal
nerve fiber layer thickness and cup to disc ratio. Data was analysed by using descriptive statistics and chi-square test with
SPSS version 20.
Results: In 2 months there was 16(66.66%) normal fundus, 8(33.33%) glaucomatous optic disc cupping. In 4 months, there
was 12(15.38%) normal fundus, 16(20%) optic atrophy, 16(20%) optic neuropathy, 4.00(5%) optic neuritis and 30(38%)
glaucomatous optic disc cupping. In 6 months, there was 7(21%) normal fundus, 4(12.5%) optic atrophy and 21(50%) optic
neuropathy. In 8 months, there was 24(36%) optic atrophy, 34(51.5%) optic neuropathy, 4(6%) optic neuritis and 4(6%)
Glaucomatous optic dis cupping (P 0.00). Result of this study also shows that retinal nerve fiber layer thickness is normal
in 83(41.5%), increase in 4(2.0%) and decrease in 113(56.5%).
Conclusions: This study concluded that anti-tuberculosis drugs responsible for optic nerve changes and severity of optic
nerve changes increase when duration of therapy increases.


Nitu FM, Olteanu M, Streba CT, Jimborean G, Postolache P,

Man MA, et al. Tuberculosis and its particularities in Romania

and worldwide. Rom J Morphol Embryol. 2017; 58(2): 385-

Fukunaga R, Glaziou P, Harris JB, Date A, Floyd K, Kasaeva

T. Epidemiology of tuberculosis and progress toward meeting

global targets—worldwide, 2019. Morbidity and Mortality

Weekly Report. 2021; 70(12):427-430. doi: 10.15585/mmwr.


Qadeer E, Fatima R, Yaqoob A, Tahseen S, Ul Haq M, Ghafoor

A, et al. Population based national tuberculosis prevalence

survey among adults (> 15 years) in Pakistan, 2010–2011.

PloS one. 2016;11(2): e0148293. journal.


Wang L, Zhang H, Ruan Y, Chin DP, Xia Y, Cheng S, et al.

Tuberculosis prevalence in China, 1990–2010; a longitudinal

analysis of national survey data. The Lancet. 2014;



Tiberi S, Scardigli A, Centis R, D’Ambrosio L, Munoz-Torrico

M, et al. Classifying new anti-tuberculosis drugs: rationale

and future perspectives. International Journal of Infectious

Diseases. 2017; 56:181-184. 10.1016/ j.ijid.


Rendon A, Tiberi S, Scardigli A, D’Ambrosio L, Centis R,

Caminero JA, et al. Classification of drugs to treat multidrugresistant tuberculosis (MDR-TB): evidence and perspectives.

Journal of thoracic disease. 2016;8(10):2666-2671. doi: 10.


Abbas A. Monitoring of Side Effects of Anti-Tuberculosis

Drugs (ATD) On The Intensive Phase Treatment Of Pulmonary

TB Patients In Makassar. Journal of Agromedicine and Medical

Sciences. 2017;3(1): 19-24. DOI: 10.19184/


Fredj NB, Gam R, Kerkni E, Chaabane A, Chadly Z,

Boughattas N, Aouam K. Risk factors of isoniazid-induced

hepatotoxicity in Tunisian tuberculosis patients. The

pharmacogenomics journal. 2017;17(4):372-377. https://

Panchal K et al. Ocular side effects of anti-tubercular drugs

in patients receiving Anti-Tb treatment at tertiary care center.

IP International Journal of Ocular Oncology and Oculoplasty.

;6(3):187-191. DOI:10.18231/j.ijooo.2020.042

Solu TM, Panchal KM. Ocular Side Effects of Anti-Tubercular

Drugs in Patients Receiving Anti-Tb Treatment at Tertiary

Care Center. Journal of dental and medical sciences. 2020;

(8):9-13. DOI: 10.9790/0853-1908100913

Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi

G. Optical coherence tomography angiography. Progress in

retinal and eye research. 2018; 64:1-55. 10.1016


Saxena R, Singh D, Phuljhele S, Kalaiselvan V, Karna S,

Gandhi R, et al. Ethambutol toxicity: Expert panel consensus

for the primary prevention, diagnosis and management of

ethambutol-induced optic neuropathy. Indian journal of

ophthalmology. 2021; 69(12):3734-9. doi: 10.4103/


Mandal S, Saxena R, Dhiman R, Mohan A, Padhy SK,

Phuljhele S, Sharma P, Guleria R. Prospective study to evaluate

incidence and indicators for early detection of ethambutol

toxicity. British Journal of Ophthalmology. 2021; 105(7):1024-

Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol

optic neuropathy. Current opinion in ophthalmology. 2017

Nov 1;28(6):545-51. DOI: /ICU.

Jin KW, Lee JY, Rhiu S, Choi DG. Longitudinal evaluation

of visual function and structure for detection of subclinical

Ethambutol-induced optic neuropathy. Plos one. 2019;

(4):e0215297. doi: 10.1371/journal.pone.0215297

Ezer N, Benedetti A, Darvish-Zargar M, Menzies D. Incidence

of ethambutol-related visual impairment during treatment of

active tuberculosis. The International journal of tuberculosis

and lung disease. 2013; 17(4):447-455. doi: 10.5588/


Konnakkodan SM, Solomon CB, Prabhu PB, Kumar AA.

Optic nerve head-retinal nerve fiber layer analysis with

spectral-domain optical coherence tomography of ethambutolinduced ocular toxicity in patients on a daily regime of antitubercular therapy. Kerala Journal of Ophthalmology. 2021;

(3):291-298. DOI:10.4103/kjo.kjo_162_20.

Raghu V, Rajender M, Beesam K, Reddy N. A Prospective

evaluation of visual function for early detection of ethambutol

toxicity. MRIMS Journal of Health Sciences. 2016; 4(2):89-


Singh PK. The Effect of Anti-Tubercular Drugs on Retinal

Nerve Fiber Layer Thickness Using Optical Coherence

Tomography. Ophthalmology Research: An International

Journal. 2020; 13(1):12-15. DOI: 10.9734/OR /2020/ v13i1

Bandyopadhyay S, Banerjee S, Bandyopadhyay SK,

Shamantha MC, Biswas S. A prospective evaluation of ocular

toxicity in patients receiving ethambutol as anti-tubercular

therapy. Sudanese Journal of Ophthalmology. 2020; 12(1):12-





How to Cite

Abbas, S. ., Sammad, S. A. ., Akhtar, M. ., Zahra, S. T. ., Gulzar, S. N. ., & Kiran, A. . (2022). Assessment of Optic Nerve Changes in Patients Receiving Anti-Tuberculosis Drugs at Different Time Interval. Journal of Bahria University Medical and Dental College, 12(03), 152–156.



Original Articles